BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 28, 2013
View Archived Issues
Ghrelin agonist tested in gastrointestinal symptoms related to Parkinson's disease
Read More
Global molecular signature for the prognosis of hepatocellular carcinoma identified
Read More
[11C]Cimbi-36 demonstrates utility for human brain imaging
Read More
Development of Sangamo BioSciences' ZFP beta-thalassemia treatment receives support
Read More
Novel pneumonia vaccine candidate induces systemic and mucosal immune response in vivo
Read More
In vivo results for a novel ApoC-II mimetic peptide reported
Read More
Oxford BioMedica develops a novel gene therapy for IOP
Read More
A novel PET tracer shows PDE10A specificity in rat and monkey striatum
Read More
Astellas Pharma will not seek European approval for tivozanib in RCC
Read More
Valeant Pharmaceuticals to acquire Bausch & Lomb
Read More
GSK and Tempero Pharmaceuticals jointly develop HDAC9 inhibitors
Read More
Recent Merck & Co. patents describe novel ROMK blockers
Read More
Novel nicotinic alpha4beta2 receptor ligands identified by Targacept
Read More
Italian researchers synthesize novel HSP 90 inhibitors
Read More
Vertex Pharmaceuticals discloses novel Na(v)1.7 blockers
Read More
Virobay begins phase I trial of oral pain treatment candidate VBY-036
Read More
PlantForm and PharmaPraxis collaborate on biosimilars/biobetters
Read More
Astellas' isavuconazole granted orphan drug status for invasive aspergillosis
Read More
Chembio awarded U.S. government contract to develop diagnostic tests
Read More
Eisai set to launch Inovelon tablets in Japan
Read More
4SC's Japanese partner Yakult Honsha begins phase I/II study of resminostat in liver cancer
Read More
Bayer's Xarelto approved in Europe for additional indication
Read More
AstraZeneca enters definitive agreement to acquire Omthera Pharmaceuticals
Read More